data_1vvc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vvc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.46 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 82.9 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.276 0.56 . . . . 2.8300000000000001 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.9 mttp -139.38 172.44 12.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 4.2800000000000002 110.311 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.526 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -134.52 88.75 2.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 1.48 110.168 -179.974 -98.19 -114.636 -75.761 104.025 2.018 104.665 -108.262 -139.078 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -66.9 171.32 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.088 . . . . 3.2999999999999998 109.122 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -43.66 143.03 1.71 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 2.4300000000000002 109.202 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 47.3 Cg_endo -69.0 158.51 57.65 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.945 1.497 . . . . 1.1100000000000001 112.074 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.09 173.49 14.35 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 1.49 109.819 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -71.11 176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 2.0800000000000001 110.146 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.584 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.89 -169.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.195 0.998 . . . . 1.52 111.409 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 51.1 m -39.37 92.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.517 -0.765 . . . . 2.5299999999999998 110.944 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m120 42.26 26.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 2.6299999999999999 110.573 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -124.71 160.27 19.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.646 -1.382 . . . . 0.88 109.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -108.61 -169.07 1.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.09 . . . . 3.8700000000000001 110.495 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.3 p80 -151.06 118.86 6.16 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.249 0.547 . . . . 1.3799999999999999 109.762 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -154.02 99.14 2.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 4.1500000000000004 110.537 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -93.55 -67.72 1.07 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.145 -1.582 . . . . 3.2200000000000002 109.145 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 167.38 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -1.103 . . . . 6.2699999999999996 110.211 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.567 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -171.44 -179.06 2.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 3.6800000000000002 110.644 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.38 -32.73 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 3.3100000000000001 110.12 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.48 139.73 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 4.25 110.01 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.567 ' CE1' ' OE2' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -127.33 -7.53 5.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 2.7400000000000002 110.647 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.526 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 60.6 p 46.07 -97.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 2.2000000000000002 111.966 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -149.49 160.97 43.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.876 -1.14 . . . . 1.8300000000000001 110.471 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 15.87 68.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.492 -1.843 . . . . 1.45 108.492 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -97.51 176.94 5.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.562 -0.964 . . . . 1.8300000000000001 110.396 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.8 t -152.09 156.0 6.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.588 -0.845 . . . . 1.6799999999999999 110.214 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 29' ' ' TYR . 24.8 t -142.04 122.02 10.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.154 -1.018 . . . . 1.4099999999999999 111.744 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.93 103.85 5.3 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.545 -1.28 . . . . 1.7 107.545 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.64 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.63 120.43 14.01 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.277 -0.889 . . . . 2.2599999999999998 109.841 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -69.69 157.84 36.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 1.75 109.9 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.4 m -127.08 156.44 41.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 1.0800000000000001 110.225 -179.802 -60.24 -59.942 -47.499 103.982 2.019 104.055 -78.217 -64.225 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.459 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -58.75 144.84 42.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 2.2400000000000002 110.191 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.53 112.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 2.5499999999999998 110.345 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.55 7.27 32.28 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 1.1599999999999999 109.66 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' CD1' ' HB3' ' A' ' 32' ' ' ASN . 23.5 m-85 -114.3 138.06 50.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -1.164 . . . . 2.4199999999999999 110.226 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.618 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -87.75 141.25 28.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 2.1899999999999999 110.778 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -91.43 101.42 14.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.36 -0.838 . . . . 1.49 109.27 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -91.09 141.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -0.99 . . . . 1.8500000000000001 109.339 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.83 -170.62 13.38 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.967 -1.653 . . . . 1.6599999999999999 108.967 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.61 144.79 55.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -1.199 . . . . 3.27 109.847 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.0 p -73.56 55.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.96 . . . . 2.46 109.83 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 153.82 126.14 1.08 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.457 -1.457 . . . . 1.1299999999999999 109.457 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.64 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.2 t -64.97 -178.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -1.207 . . . . 1.1799999999999999 107.766 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tp -142.38 96.5 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.206 -0.997 . . . . 2.02 110.395 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -83.79 106.27 15.35 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.131 -1.028 . . . . 1.01 109.173 178.638 -139.078 -108.262 -75.761 104.665 2.018 104.025 -114.636 -98.19 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.0 100.8 5.57 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.719 -0.792 . . . . 2.25 110.373 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 102.76 21.5 10.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.507 -1.437 . . . . 1.3700000000000001 109.507 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 73.94 28.27 65.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.561 -1.416 . . . . 1.26 109.561 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -147.59 91.35 1.95 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 2.2799999999999998 110.362 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 85.6 m95 -46.29 138.02 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.89000000000000001 109.8 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 t -142.17 159.12 42.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 2.1299999999999999 111.032 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 62.17 66.95 1.31 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.734 -0.604 . . . . 2.2799999999999998 111.06 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.2 Cg_endo -90.82 129.71 1.43 Allowed 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.328 1.699 . . . . 1.23 110.237 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -77.05 175.83 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.908 1.478 . . . . 1.1399999999999999 110.113 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -119.7 146.55 45.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.124 -0.985 . . . . 1.6499999999999999 111.572 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 10' ' ' SER . 82.8 m -110.26 81.38 1.43 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.324 -0.991 . . . . 1.1899999999999999 108.324 177.886 -64.225 -78.217 -47.499 104.055 2.019 103.982 -59.942 -60.24 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.9 mm100 -114.54 -151.56 0.49 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.475 0.655 . . . . 2.6299999999999999 110.398 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.55 130.01 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.823 -0.806 . . . . 1.9099999999999999 108.823 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 27.5 m -120.44 48.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 1.6200000000000001 111.368 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -63.48 -168.15 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 118.641 -1.223 . . . . 2.9900000000000002 108.784 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -147.57 164.0 24.9 Favored Pre-proline 0 C--N 1.294 -1.826 0 C-N-CA 118.922 -1.111 . . . . 1.3400000000000001 112.577 -178.988 -125.098 105.311 123.627 103.066 2.011 103.816 92.898 -179.426 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.4 Cg_endo -89.49 -62.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.815 1.955 . . . . 0.82999999999999996 108.85 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.78 125.62 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.757 -0.831 . . . . 1.3 108.757 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.611 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 51.6 Cg_endo -76.3 69.12 6.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.744 1.391 . . . . 0.65000000000000002 109.259 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.543 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -87.63 -177.19 5.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 1.6100000000000001 110.029 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 179.51 163.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.002 . . . . 1.28 110.407 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -69.73 105.52 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 1.95 110.484 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.535 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.5 m-20 39.65 42.79 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.757 . . . . 2.3500000000000001 110.736 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -150.26 30.28 1.08 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.64 -1.384 . . . . 1.3600000000000001 109.64 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' ' O ' ' A' ' 69' ' ' GLY . 4.5 p90 -44.57 -173.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.693 1.235 . . . . 2.8399999999999999 112.536 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -111.59 163.46 14.06 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.118 -0.946 . . . . 2.23 110.346 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -145.82 25.14 1.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.025 -1.047 . . . . 2.3700000000000001 110.19 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 27.8 t -107.91 -79.02 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 2.5 110.933 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.12 76.34 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 1.8600000000000001 109.905 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.2 t80 -103.24 162.9 12.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -1.06 . . . . 2.46 109.845 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 mttm -163.71 155.77 17.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 2.9100000000000001 110.273 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -51.61 -28.33 13.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.057 . . . . 3.4900000000000002 109.975 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.417 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.9 t -144.8 156.74 44.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 2.1000000000000001 110.167 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 7.8 m-85 -131.51 -158.24 0.88 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 2.3999999999999999 109.906 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 87.5 p -150.07 -123.15 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.159 . . . . 2.2200000000000002 110.862 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -96.98 16.07 20.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.473 -1.392 . . . . 2.6200000000000001 110.106 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 103' ' ' CYS . 4.4 p30 -159.36 -102.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.924 -1.11 . . . . 3.5899999999999999 110.327 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' C ' HG21 ' A' ' 102' ' ' THR . 2.1 t0 45.34 75.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.897 -1.127 . . . . 2.0800000000000001 109.05 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 9.8 t-20 -69.52 130.68 43.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 3.0600000000000001 110.935 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 HG12 ' CH2' ' A' ' 109' ' ' TRP . 16.9 m -115.54 120.42 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.913 . . . . 1.4399999999999999 110.295 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 47.9 m-20 -80.91 130.8 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 1.6299999999999999 108.729 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 36.3 m-85 -90.95 129.48 36.97 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 2.1600000000000001 111.865 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 70' ' ' TYR . 6.4 tttp -106.74 94.38 5.09 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.629 -0.714 . . . . 2.8500000000000001 110.066 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.47 131.96 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.112 -0.993 . . . . 1.26 109.789 179.822 -133.83 -40.753 134.943 104.19 2.023 106.006 37.51 -151.856 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.535 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 7.7 mttt -41.35 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.345 -0.847 . . . . 2.6600000000000001 110.45 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -161.69 137.9 8.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.373 -0.83 . . . . 4.3399999999999999 110.364 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.88 55.56 20.3 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.481 -1.447 . . . . 1.97 109.481 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 14.2 m-85 -158.08 151.45 23.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 2.96 109.725 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 17.3 tttp -107.82 132.33 53.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 3.4199999999999999 109.927 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.0 OUTLIER -71.89 92.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 1.3500000000000001 110.352 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.84 100.18 1.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 1.45 109.653 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.62 -90.88 0.17 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.808 -1.317 . . . . 1.0700000000000001 109.808 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.4 t -156.44 116.08 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 1.76 110.561 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -73.75 1.22 10.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 1.8700000000000001 110.772 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.5 p -146.28 106.6 4.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 1.5600000000000001 109.825 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 12.5 m -122.1 172.38 8.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 1.1399999999999999 110.846 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -142.93 138.38 30.11 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.894 -0.722 . . . . 1.6000000000000001 110.288 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 54.0 t -65.76 99.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.526 -0.734 . . . . 1.24 109.752 179.777 -179.426 92.898 123.627 103.816 2.011 103.066 105.311 -125.098 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -79.87 174.87 5.43 Favored Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.301 -0.874 . . . . 2.1299999999999999 110.547 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.3 Cg_endo -73.45 125.56 10.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 124.256 1.661 . . . . 1.5700000000000001 110.887 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.79 -1.87 6.88 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.285 -1.526 . . . . 1.8100000000000001 109.285 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 3.7 t30 77.83 87.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.687 -0.89 . . . . 2.3900000000000001 110.939 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.49 -161.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.892 . . . . 1.3700000000000001 111.486 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.617 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 27.6 m95 -142.75 94.59 2.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.468 0.651 . . . . 0.78000000000000003 110.15 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -103.32 142.27 24.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 3.1099999999999999 110.324 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.4 Cg_endo -71.9 172.91 54.26 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.013 -2.078 . . . . 1.1799999999999999 110.752 -0.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -40.87 127.54 2.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 2.77 110.881 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.55 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.05 145.35 0.57 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.778 . . . . 1.4399999999999999 110.103 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.578 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.3 Cg_endo -71.74 168.38 23.91 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 124.258 1.662 . . . . 0.60999999999999999 110.943 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.5 108.0 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -0.841 . . . . 2.5600000000000001 110.356 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -64.94 94.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.23 109.114 179.454 -151.856 37.51 134.943 106.006 2.023 104.19 -40.753 -133.83 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -108.83 -174.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.792 0.806 . . . . 1.6799999999999999 110.882 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.294 -1.818 0 CA-C-O 118.004 -0.998 . . . . 4.6299999999999999 110.324 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 82.9 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.276 0.56 . . . . 2.3399999999999999 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.9 mttp -139.38 172.44 12.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 3.8999999999999999 110.311 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -134.52 88.75 2.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 1.47 110.168 -179.974 -98.19 -114.636 -75.761 104.025 2.018 104.665 -108.262 -139.078 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -66.9 171.32 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.088 . . . . 2.9399999999999999 109.122 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -43.66 143.03 1.71 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 2.0699999999999998 109.202 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.9 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.3 Cg_endo -69.0 158.51 57.65 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.945 1.497 . . . . 1.1100000000000001 112.074 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.09 173.49 14.35 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 1.3100000000000001 109.819 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -71.11 176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 1.6499999999999999 110.146 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.89 -169.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.195 0.998 . . . . 1.22 111.409 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 51.1 m -39.37 92.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.517 -0.765 . . . . 2.2799999999999998 110.944 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m120 42.26 26.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 2.6299999999999999 110.573 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -124.71 160.27 19.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.646 -1.382 . . . . 0.88 109.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -108.61 -169.07 1.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.09 . . . . 3.3599999999999999 110.495 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.3 p80 -151.06 118.86 6.16 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.249 0.547 . . . . 1.3500000000000001 109.762 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.02 99.14 2.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 3.5899999999999999 110.537 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -93.55 -67.72 1.07 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.145 -1.582 . . . . 3.2200000000000002 109.145 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 167.38 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -1.103 . . . . 6.0700000000000003 110.211 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.567 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -171.44 -179.06 2.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 3.6800000000000002 110.644 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.38 -32.73 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 3.3100000000000001 110.12 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.48 139.73 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 3.5699999999999998 110.01 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.567 ' CE1' ' OE2' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -127.33 -7.53 5.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 2.2799999999999998 110.647 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 60.6 p 46.07 -97.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 1.8100000000000001 111.966 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -149.49 160.97 43.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.876 -1.14 . . . . 1.8300000000000001 110.471 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 15.87 68.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.492 -1.843 . . . . 1.45 108.492 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -97.51 176.94 5.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.562 -0.964 . . . . 1.51 110.396 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.8 t -152.09 156.0 6.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.588 -0.845 . . . . 1.28 110.214 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.8 t -142.04 122.02 10.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.154 -1.018 . . . . 0.83999999999999997 111.744 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.93 103.85 5.3 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.545 -1.28 . . . . 1.25 107.545 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.054 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.63 120.43 14.01 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.277 -0.889 . . . . 1.3500000000000001 109.841 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -69.69 157.84 36.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 1.3600000000000001 109.9 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 37' ' ' LEU . 81.4 m -127.08 156.44 41.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 1.03 110.225 -179.802 -60.24 -59.942 -47.499 103.982 2.019 104.055 -78.217 -64.225 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -58.75 144.84 42.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 1.8600000000000001 110.191 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.53 112.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 2.1400000000000001 110.345 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.55 7.27 32.28 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 1.1000000000000001 109.66 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 23.5 m-85 -114.3 138.06 50.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -1.164 . . . . 1.6100000000000001 110.226 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.637 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -87.75 141.25 28.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 1.8899999999999999 110.778 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -91.43 101.42 14.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.36 -0.838 . . . . 1.2 109.27 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.787 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -91.09 141.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -0.99 . . . . 1.3999999999999999 109.339 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.83 -170.62 13.38 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.967 -1.653 . . . . 1.6599999999999999 108.967 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.61 144.79 55.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -1.199 . . . . 2.8599999999999999 109.847 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 28' ' ' THR . 77.0 p -73.56 55.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.96 . . . . 2.1800000000000002 109.83 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.82 126.14 1.08 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.457 -1.457 . . . . 1.1200000000000001 109.457 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -64.97 -178.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -1.207 . . . . 0.93999999999999995 107.766 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.4 tp -142.38 96.5 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.206 -0.997 . . . . 1.54 110.395 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -83.79 106.27 15.35 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.131 -1.028 . . . . 1.01 109.173 178.638 -139.078 -108.262 -75.761 104.665 2.018 104.025 -114.636 -98.19 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.0 100.8 5.57 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.719 -0.792 . . . . 1.8200000000000001 110.373 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 102.76 21.5 10.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.507 -1.437 . . . . 1.24 109.507 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 73.94 28.27 65.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.561 -1.416 . . . . 1.1299999999999999 109.561 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -147.59 91.35 1.95 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 2.2799999999999998 110.362 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 85.6 m95 -46.29 138.02 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.89000000000000001 109.8 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 t -142.17 159.12 42.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.77 111.032 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 62.17 66.95 1.31 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.734 -0.604 . . . . 2.2799999999999998 111.06 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.2 Cg_endo -90.82 129.71 1.43 Allowed 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.328 1.699 . . . . 1.1100000000000001 110.237 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -77.05 175.83 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.908 1.478 . . . . 1.02 110.113 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -119.7 146.55 45.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.124 -0.985 . . . . 1.22 111.572 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 10' ' ' SER . 82.8 m -110.26 81.38 1.43 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.324 -0.991 . . . . 1.1899999999999999 108.324 177.886 -64.225 -78.217 -47.499 104.055 2.019 103.982 -59.942 -60.24 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.9 mm100 -114.54 -151.56 0.49 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.475 0.655 . . . . 2.3100000000000001 110.398 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -117.55 130.01 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.823 -0.806 . . . . 1.45 108.823 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.637 HG13 ' CB ' ' A' ' 36' ' ' SER . 27.5 m -120.44 48.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 1.1699999999999999 111.368 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -63.48 -168.15 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 118.641 -1.223 . . . . 2.48 108.784 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -147.57 164.0 24.9 Favored Pre-proline 0 C--N 1.294 -1.826 0 C-N-CA 118.922 -1.111 . . . . 1.1699999999999999 112.577 -178.988 -125.098 105.311 123.627 103.066 2.011 103.816 92.898 -179.426 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.4 Cg_endo -89.49 -62.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.815 1.955 . . . . 0.82999999999999996 108.85 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.78 125.62 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.757 -0.831 . . . . 0.93000000000000005 108.757 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.637 ' HA ' HD21 ' A' ' 113' ' ' LEU . 51.6 Cg_endo -76.3 69.12 6.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.744 1.391 . . . . 0.65000000000000002 109.259 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.715 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -87.63 -177.19 5.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 1.4299999999999999 110.029 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 179.51 163.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.002 . . . . 0.92000000000000004 110.407 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -69.73 105.52 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 1.5800000000000001 110.484 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.5 m-20 39.65 42.79 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.757 . . . . 1.9299999999999999 110.736 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.772 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.26 30.28 1.08 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.64 -1.384 . . . . 1.3600000000000001 109.64 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' ' O ' ' A' ' 69' ' ' GLY . 4.5 p90 -44.57 -173.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.693 1.235 . . . . 2.0099999999999998 112.536 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.59 163.46 14.06 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.118 -0.946 . . . . 1.6200000000000001 110.346 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -145.82 25.14 1.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.025 -1.047 . . . . 2.1200000000000001 110.19 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 27.8 t -107.91 -79.02 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 2.04 110.933 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.12 76.34 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 1.8600000000000001 109.905 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.2 t80 -103.24 162.9 12.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -1.06 . . . . 1.6200000000000001 109.845 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 mttm -163.71 155.77 17.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 2.4100000000000001 110.273 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -51.61 -28.33 13.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.057 . . . . 2.8999999999999999 109.975 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.417 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.9 t -144.8 156.74 44.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.6399999999999999 110.167 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 7.8 m-85 -131.51 -158.24 0.88 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 1.5 109.906 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 87.5 p -150.07 -123.15 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.159 . . . . 2.2200000000000002 110.862 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -96.98 16.07 20.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.473 -1.392 . . . . 1.8700000000000001 110.106 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.754 ' C ' HG22 ' A' ' 102' ' ' THR . 4.4 p30 -159.36 -102.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.924 -1.11 . . . . 2.9399999999999999 110.327 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.1 t0 45.34 75.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.897 -1.127 . . . . 2.0800000000000001 109.05 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.877 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.8 t-20 -69.52 130.68 43.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 2.52 110.935 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.9 m -115.54 120.42 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.913 . . . . 0.92000000000000004 110.295 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 47.9 m-20 -80.91 130.8 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 1.6299999999999999 108.729 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.701 ' CE1' HD12 ' A' ' 71' ' ' LEU . 36.3 m-85 -90.95 129.48 36.97 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 1.3 111.865 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 70' ' ' TYR . 6.4 tttp -106.74 94.38 5.09 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.629 -0.714 . . . . 2.4199999999999999 110.066 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.6 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.47 131.96 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.112 -0.993 . . . . 1.26 109.789 179.822 -133.83 -40.753 134.943 104.19 2.023 106.006 37.51 -151.856 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 7.7 mttt -41.35 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.345 -0.847 . . . . 2.2799999999999998 110.45 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -161.69 137.9 8.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.373 -0.83 . . . . 4.1200000000000001 110.364 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.88 55.56 20.3 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.481 -1.447 . . . . 1.79 109.481 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 14.2 m-85 -158.08 151.45 23.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 2.21 109.725 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 117' ' ' VAL . 17.3 tttp -107.82 132.33 53.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 3.0499999999999998 109.927 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.0 OUTLIER -71.89 92.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.90000000000000002 110.352 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.84 100.18 1.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 1.1399999999999999 109.653 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.62 -90.88 0.17 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.808 -1.317 . . . . 1.0700000000000001 109.808 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.603 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.4 t -156.44 116.08 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 1.4099999999999999 110.561 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -73.75 1.22 10.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 1.51 110.772 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.5 p -146.28 106.6 4.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 1.1499999999999999 109.825 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 12.5 m -122.1 172.38 8.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.92000000000000004 110.846 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.877 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -142.93 138.38 30.11 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.894 -0.722 . . . . 1.26 110.288 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 54.0 t -65.76 99.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.526 -0.734 . . . . 1.24 109.752 179.777 -179.426 92.898 123.627 103.816 2.011 103.066 105.311 -125.098 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -79.87 174.87 5.43 Favored Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.301 -0.874 . . . . 1.6899999999999999 110.547 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.787 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -73.45 125.56 10.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 124.256 1.661 . . . . 1.5700000000000001 110.887 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.79 -1.87 6.88 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.285 -1.526 . . . . 1.3700000000000001 109.285 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 108' ' ' THR . 3.7 t30 77.83 87.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.687 -0.89 . . . . 1.95 110.939 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.49 -161.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.892 . . . . 0.81000000000000005 111.486 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.737 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.6 m95 -142.75 94.59 2.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.468 0.651 . . . . 0.68999999999999995 110.15 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.546 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -103.32 142.27 24.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 2.6400000000000001 110.324 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.603 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.4 Cg_endo -71.9 172.91 54.26 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.013 -2.078 . . . . 1.05 110.752 -0.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -40.87 127.54 2.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 2.77 110.881 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.05 145.35 0.57 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.778 . . . . 0.84999999999999998 110.103 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.721 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.3 Cg_endo -71.74 168.38 23.91 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 124.258 1.662 . . . . 0.59999999999999998 110.943 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.965 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.5 108.0 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -0.841 . . . . 2.1299999999999999 110.356 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -64.94 94.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.23 109.114 179.454 -151.856 37.51 134.943 106.006 2.023 104.19 -40.753 -133.83 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -108.83 -174.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.792 0.806 . . . . 1.3400000000000001 110.882 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.294 -1.818 0 CA-C-O 118.004 -0.998 . . . . 3.98 110.324 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 82.9 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.276 0.56 . . . . 2.34 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.9 mttp -139.38 172.44 12.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 3.9 110.311 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -134.52 88.75 2.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 1.47 110.168 -179.974 -98.19 -114.636 -75.761 104.025 2.018 104.665 -108.262 -139.078 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -66.9 171.32 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.088 . . . . 2.94 109.122 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -43.66 143.03 1.71 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 2.07 109.202 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.9 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.3 Cg_endo -69.0 158.51 57.65 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.945 1.497 . . . . 1.11 112.074 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.09 173.49 14.35 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 1.31 109.819 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -71.11 176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 1.65 110.146 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.89 -169.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.195 0.998 . . . . 1.22 111.409 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 51.1 m -39.37 92.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.517 -0.765 . . . . 2.28 110.944 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m120 42.26 26.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 2.63 110.573 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -124.71 160.27 19.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.646 -1.382 . . . . 0.88 109.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -108.61 -169.07 1.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.09 . . . . 3.36 110.495 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.3 p80 -151.06 118.86 6.16 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.249 0.547 . . . . 1.35 109.762 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -154.02 99.14 2.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 3.59 110.537 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -93.55 -67.72 1.07 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.145 -1.582 . . . . 3.22 109.145 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 167.38 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -1.103 . . . . 6.07 110.211 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.567 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -171.44 -179.06 2.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 3.68 110.644 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.38 -32.73 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 3.31 110.12 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.48 139.73 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 3.57 110.01 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.567 ' CE1' ' OE2' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -127.33 -7.53 5.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 2.28 110.647 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 60.6 p 46.07 -97.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 1.81 111.966 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -149.49 160.97 43.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.876 -1.14 . . . . 1.83 110.471 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 15.87 68.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.492 -1.843 . . . . 1.45 108.492 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -97.51 176.94 5.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.562 -0.964 . . . . 1.51 110.396 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.8 t -152.09 156.0 6.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.588 -0.845 . . . . 1.28 110.214 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.8 t -142.04 122.02 10.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.154 -1.018 . . . . 0.84 111.744 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.93 103.85 5.3 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.545 -1.28 . . . . 1.25 107.545 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.054 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.63 120.43 14.01 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.277 -0.889 . . . . 1.35 109.841 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -69.69 157.84 36.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 1.36 109.9 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 37' ' ' LEU . 81.4 m -127.08 156.44 41.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 1.03 110.225 -179.802 -60.24 -59.942 -47.499 103.982 2.019 104.055 -78.217 -64.225 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -58.75 144.84 42.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 1.86 110.191 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.53 112.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 2.14 110.345 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.55 7.27 32.28 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 1.1 109.66 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 23.5 m-85 -114.3 138.06 50.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -1.164 . . . . 1.61 110.226 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.637 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -87.75 141.25 28.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 1.89 110.778 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -91.43 101.42 14.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.36 -0.838 . . . . 1.2 109.27 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.787 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -91.09 141.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -0.99 . . . . 1.4 109.339 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.83 -170.62 13.38 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.967 -1.653 . . . . 1.66 108.967 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.61 144.79 55.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -1.199 . . . . 2.86 109.847 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 28' ' ' THR . 77.0 p -73.56 55.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.96 . . . . 2.18 109.83 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.82 126.14 1.08 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.457 -1.457 . . . . 1.12 109.457 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -64.97 -178.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -1.207 . . . . 0.94 107.766 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.4 tp -142.38 96.5 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.206 -0.997 . . . . 1.54 110.395 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -83.79 106.27 15.35 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.131 -1.028 . . . . 1.01 109.173 178.638 -139.078 -108.262 -75.761 104.665 2.018 104.025 -114.636 -98.19 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.0 100.8 5.57 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.719 -0.792 . . . . 1.82 110.373 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 102.76 21.5 10.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.507 -1.437 . . . . 1.24 109.507 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 73.94 28.27 65.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.561 -1.416 . . . . 1.13 109.561 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -147.59 91.35 1.95 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 2.28 110.362 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 85.6 m95 -46.29 138.02 5.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.89 109.8 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 t -142.17 159.12 42.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.77 111.032 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 62.17 66.95 1.31 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.734 -0.604 . . . . 2.28 111.06 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.2 Cg_endo -90.82 129.71 1.43 Allowed 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.328 1.699 . . . . 1.11 110.237 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -77.05 175.83 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.908 1.478 . . . . 1.02 110.113 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -119.7 146.55 45.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.124 -0.985 . . . . 1.22 111.572 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 10' ' ' SER . 82.8 m -110.26 81.38 1.43 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.324 -0.991 . . . . 1.19 108.324 177.886 -64.225 -78.217 -47.499 104.055 2.019 103.982 -59.942 -60.24 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.9 mm100 -114.54 -151.56 0.49 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.475 0.655 . . . . 2.31 110.398 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.695 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -117.55 130.01 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.823 -0.806 . . . . 1.45 108.823 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.637 HG13 ' CB ' ' A' ' 36' ' ' SER . 27.5 m -120.44 48.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 1.17 111.368 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -63.48 -168.15 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 118.641 -1.223 . . . . 2.48 108.784 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -147.57 164.0 24.9 Favored Pre-proline 0 C--N 1.294 -1.826 0 C-N-CA 118.922 -1.111 . . . . 1.17 112.577 -178.988 -125.098 105.311 123.627 103.066 2.011 103.816 92.898 -179.426 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.4 Cg_endo -89.49 -62.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.815 1.955 . . . . 0.83 108.85 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.78 125.62 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.757 -0.831 . . . . 0.93 108.757 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.637 ' HA ' HD21 ' A' ' 113' ' ' LEU . 51.6 Cg_endo -76.3 69.12 6.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.744 1.391 . . . . 0.65 109.259 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.715 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -87.63 -177.19 5.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 1.43 110.029 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 179.51 163.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.002 . . . . 0.92 110.407 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -69.73 105.52 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 1.58 110.484 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.5 m-20 39.65 42.79 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.757 . . . . 1.93 110.736 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.772 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.26 30.28 1.08 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.64 -1.384 . . . . 1.36 109.64 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' ' O ' ' A' ' 69' ' ' GLY . 4.5 p90 -44.57 -173.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.693 1.235 . . . . 2.01 112.536 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.736 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.59 163.46 14.06 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.118 -0.946 . . . . 1.62 110.346 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -145.82 25.14 1.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.025 -1.047 . . . . 2.12 110.19 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 27.8 t -107.91 -79.02 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 2.04 110.933 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.12 76.34 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 1.86 109.905 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.2 t80 -103.24 162.9 12.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -1.06 . . . . 1.62 109.845 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 mttm -163.71 155.77 17.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 2.41 110.273 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -51.61 -28.33 13.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.057 . . . . 2.9 109.975 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.417 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.9 t -144.8 156.74 44.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.64 110.167 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 7.8 m-85 -131.51 -158.24 0.88 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 1.5 109.906 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 87.5 p -150.07 -123.15 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.159 . . . . 2.22 110.862 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -96.98 16.07 20.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.473 -1.392 . . . . 1.87 110.106 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.754 ' C ' HG22 ' A' ' 102' ' ' THR . 4.4 p30 -159.36 -102.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.924 -1.11 . . . . 2.94 110.327 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.1 t0 45.34 75.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.897 -1.127 . . . . 2.08 109.05 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.877 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.8 t-20 -69.52 130.68 43.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 2.52 110.935 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.9 m -115.54 120.42 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.913 . . . . 0.92 110.295 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 47.9 m-20 -80.91 130.8 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 1.63 108.729 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.701 ' CE1' HD12 ' A' ' 71' ' ' LEU . 36.3 m-85 -90.95 129.48 36.97 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 1.3 111.865 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 70' ' ' TYR . 6.4 tttp -106.74 94.38 5.09 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.629 -0.714 . . . . 2.42 110.066 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.6 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.47 131.96 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.112 -0.993 . . . . 1.26 109.789 179.822 -133.83 -40.753 134.943 104.19 2.023 106.006 37.51 -151.856 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 7.7 mttt -41.35 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.345 -0.847 . . . . 2.28 110.45 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -161.69 137.9 8.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.373 -0.83 . . . . 4.12 110.364 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.88 55.56 20.3 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.481 -1.447 . . . . 1.79 109.481 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 14.2 m-85 -158.08 151.45 23.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -1.082 . . . . 2.21 109.725 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 117' ' ' VAL . 17.3 tttp -107.82 132.33 53.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 3.05 109.927 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.0 OUTLIER -71.89 92.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.9 110.352 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.84 100.18 1.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 1.14 109.653 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.62 -90.88 0.17 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.808 -1.317 . . . . 1.07 109.808 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.603 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.4 t -156.44 116.08 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 1.41 110.561 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -73.75 1.22 10.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 1.51 110.772 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.5 p -146.28 106.6 4.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 1.15 109.825 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 12.5 m -122.1 172.38 8.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.92 110.846 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.877 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -142.93 138.38 30.11 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.894 -0.722 . . . . 1.26 110.288 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 54.0 t -65.76 99.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.526 -0.734 . . . . 1.24 109.752 179.777 -179.426 92.898 123.627 103.816 2.011 103.066 105.311 -125.098 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -79.87 174.87 5.43 Favored Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.301 -0.874 . . . . 1.69 110.547 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.787 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -73.45 125.56 10.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 124.256 1.661 . . . . 1.57 110.887 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.79 -1.87 6.88 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.285 -1.526 . . . . 1.37 109.285 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 108' ' ' THR . 3.7 t30 77.83 87.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.687 -0.89 . . . . 1.95 110.939 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.49 -161.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.892 . . . . 0.81 111.486 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.737 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.6 m95 -142.75 94.59 2.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.468 0.651 . . . . 0.69 110.15 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.546 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -103.32 142.27 24.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 2.64 110.324 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.603 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.4 Cg_endo -71.9 172.91 54.26 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.013 -2.078 . . . . 1.05 110.752 -0.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -40.87 127.54 2.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 2.77 110.881 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.05 145.35 0.57 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.778 . . . . 0.85 110.103 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.721 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.3 Cg_endo -71.74 168.38 23.91 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 124.258 1.662 . . . . 0.6 110.943 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.965 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.5 108.0 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -0.841 . . . . 2.13 110.356 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -64.94 94.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.23 109.114 179.454 -151.856 37.51 134.943 106.006 2.023 104.19 -40.753 -133.83 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.965 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -108.83 -174.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.792 0.806 . . . . 1.34 110.882 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.294 -1.818 0 CA-C-O 118.004 -0.998 . . . . 3.98 110.324 179.651 . . . . . . . . 2 2 . 1 stop_ save_